Interferon-induced protein 10 and interleukin 8: C-X-C chemokines present in proliferative diabetic retinopathy

Archives of Ophthalmology

Volumn 116, Issue 12, 1998, Pages 1597-1601

  Elner, Susan G ^a   Strieter, Robert ^b   Bian, Zong Mei ^a   Kunkel, Steven ^b   Mokhtarzaden, Leila ^a   Johnson, Mark ^a   Lukacs, Nicholas ^b   Elner, Victor M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; INTERFERON INDUCED PROTEIN 10; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA HOLE; VITRECTOMY; VITREOUS BODY;

EID: 0032423826     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.12.1597     Document Type: Article

References (24)

1. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
2. Boulton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol. 1997;81:228-233.
3. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metabol. 1997;23:125-130.
4. Ambati J, Chalam KV, Chawla DK, et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997;115:1161-1166.
5. Strieter RM, Kunkel SL, Elner VM, et al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol. 1992;141:1279-1284.
6. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
7. Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res. 1995;14:1045-1053.
8. Elner VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL-8) gene expression by cytokine treated retinal pigment epithelial cells. Am J Pathol. 1990;236:745-750.
9. Bian ZM, Elner SG, Strieter RM, et al. Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells. J Leukocyte Biol. 1996;60:405-414.
10. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukocyte Biol. 1997;62:246-257.
11. Angiolillo AL, Sgadari C, Taub DD, et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995;182:1301-1314.
12. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995;210:51-57.
13. Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348-27357.
14. Evanoff HL, Burdick MD, Moore SA, Kunkel SL, Strieter RM. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol Invest. 1992;21:39-45.
15. Arenberg DA, Kunkel SL, Polverini PL, et al. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 1996; 184:981-992.
16. Koch AE, Kunkel SL, Shah MR, HosakaS, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM. Growth-related gene product alpha: A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol. 1995;155:3660-3666.
17. Kaulfmann DJH, van Meurs JC, Mertens DAE, Perperkamp E, Master C, Gerritsen ME. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:900-906.
18. DeBoer JH, Hack CE, Verhoeven AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1993;34:3376-3385.
19. Luster AD, Unkeless JC, Ravetch JF. Gamma-interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature. 1985;325:672-676.
20. Goebeler M, Yoshimura T, Toksoy A, Ritter U, Brocker EB, Gillitzer R. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Derm. 1997;108:445-451.
21. Ham JM, Kunkel SL, Dibb CR, Standiford TJ, Rolfe MW, Strieter RM. Chemotactic cytokine (IL-8 and MCP-1) gene expression by human whole blood. Immunol Invest. 1991;20:387-394.
22. Sylvester I, Yoshimura T, Sticherling M, et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest. 1992;90:471-481.
23. Narumi S, Tominaga Y, Tamaru M, et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol. 1997;158:5536-5544.
24. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes. 1997;46:26S-30S.